Anders Jakobsen

13PUBLICATIONS
21CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 08, 2025
Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients.

Morten Ladekarl, Mette Louise Mørk, Emma Skotte Albertsen

|Nov 15, 2023
Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer.

Louise Faaborg, Rikke Fredslund Andersen, Sara Wc Wen

|May 08, 2023
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors - can we RECIST? Focus on colorectal cancer.

Karen-Lise Garm Spindler, Anders Jakobsen

|May 03, 2023
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Sara Witting Christensen Wen, Line Nederby, Rikke Fredslund Andersen

|Sep 12, 2022
OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol.

Louise Bach Callesen, Torben Frøstrup Hansen, Rikke Fredslund Andersen

|May 14, 2022
Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer-A Systematic Review.

Sara Witting Christensen Wen, Jan Wen, Torben Frøstrup Hansen

Pageof 3

Frequent Collaborators

6 joint publications

Torben Schjødt Hansen

4 joint publications

Sara Witting Christensen Wen

2 joint publications

Lars Henrik Jensen

2 joint publications

Rikke Fredslund Andersen